These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 24211208

  • 1. Cholesterol glucosylation is catalyzed by transglucosylation reaction of β-glucosidase 1.
    Akiyama H, Kobayashi S, Hirabayashi Y, Murakami-Murofushi K.
    Biochem Biophys Res Commun; 2013 Nov 29; 441(4):838-43. PubMed ID: 24211208
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Beta-glucosidase 1 (GBA1) is a second bile acid β-glucosidase in addition to β-glucosidase 2 (GBA2). Study in β-glucosidase deficient mice and humans.
    Harzer K, Blech-Hermoni Y, Goldin E, Felderhoff-Mueser U, Igney C, Sidransky E, Yildiz Y.
    Biochem Biophys Res Commun; 2012 Jun 29; 423(2):308-12. PubMed ID: 22659419
    [Abstract] [Full Text] [Related]

  • 5. Novel sterol glucosyltransferase in the animal tissue and cultured cells: evidence that glucosylceramide as glucose donor.
    Akiyama H, Sasaki N, Hanazawa S, Gotoh M, Kobayashi S, Hirabayashi Y, Murakami-Murofushi K.
    Biochim Biophys Acta; 2011 May 29; 1811(5):314-22. PubMed ID: 21397038
    [Abstract] [Full Text] [Related]

  • 6. High β-glucosidase (GBA) activity not attributable to GBA1 and GBA2 in live normal and enzyme-deficient fibroblasts may emphasise the role of additional GBAs.
    Harzer K, Yildiz Y.
    Biol Chem; 2015 Nov 29; 396(11):1241-6. PubMed ID: 25996484
    [Abstract] [Full Text] [Related]

  • 7. Glucosylated cholesterol in mammalian cells and tissues: formation and degradation by multiple cellular β-glucosidases.
    Marques AR, Mirzaian M, Akiyama H, Wisse P, Ferraz MJ, Gaspar P, Ghauharali-van der Vlugt K, Meijer R, Giraldo P, Alfonso P, Irún P, Dahl M, Karlsson S, Pavlova EV, Cox TM, Scheij S, Verhoek M, Ottenhoff R, van Roomen CP, Pannu NS, van Eijk M, Dekker N, Boot RG, Overkleeft HS, Blommaart E, Hirabayashi Y, Aerts JM.
    J Lipid Res; 2016 Mar 29; 57(3):451-63. PubMed ID: 26724485
    [Abstract] [Full Text] [Related]

  • 8. Increased glucocerebrosidase (GBA) 2 activity in GBA1 deficient mice brains and in Gaucher leucocytes.
    Burke DG, Rahim AA, Waddington SN, Karlsson S, Enquist I, Bhatia K, Mehta A, Vellodi A, Heales S.
    J Inherit Metab Dis; 2013 Sep 29; 36(5):869-72. PubMed ID: 23151684
    [Abstract] [Full Text] [Related]

  • 9. Assay of β-glucosidase 2 (GBA2) activity using lithocholic acid β-3-O-glucoside substrate for cultured fibroblasts and glucosylceramide for brain tissue.
    Harzer K, Yildiz Y, Beck-Wödl S.
    Biol Chem; 2019 May 27; 400(6):745-752. PubMed ID: 30864417
    [Abstract] [Full Text] [Related]

  • 10. The non-lysosomal β-glucosidase GBA2 is a non-integral membrane-associated protein at the endoplasmic reticulum (ER) and Golgi.
    Körschen HG, Yildiz Y, Raju DN, Schonauer S, Bönigk W, Jansen V, Kremmer E, Kaupp UB, Wachten D.
    J Biol Chem; 2013 Feb 01; 288(5):3381-93. PubMed ID: 23250757
    [Abstract] [Full Text] [Related]

  • 11. The cytosolic β-glucosidase GBA3 does not influence type 1 Gaucher disease manifestation.
    Dekker N, Voorn-Brouwer T, Verhoek M, Wennekes T, Narayan RS, Speijer D, Hollak CE, Overkleeft HS, Boot RG, Aerts JM.
    Blood Cells Mol Dis; 2011 Jan 15; 46(1):19-26. PubMed ID: 20728381
    [Abstract] [Full Text] [Related]

  • 12. Identification of a feedback loop involving β-glucosidase 2 and its product sphingosine sheds light on the molecular mechanisms in Gaucher disease.
    Schonauer S, Körschen HG, Penno A, Rennhack A, Breiden B, Sandhoff K, Gutbrod K, Dörmann P, Raju DN, Haberkant P, Gerl MJ, Brügger B, Zigdon H, Vardi A, Futerman AH, Thiele C, Wachten D.
    J Biol Chem; 2017 Apr 14; 292(15):6177-6189. PubMed ID: 28258214
    [Abstract] [Full Text] [Related]

  • 13. Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease.
    Yildiz Y, Hoffmann P, Vom Dahl S, Breiden B, Sandhoff R, Niederau C, Horwitz M, Karlsson S, Filocamo M, Elstein D, Beck M, Sandhoff K, Mengel E, Gonzalez MC, Nöthen MM, Sidransky E, Zimran A, Mattheisen M.
    Orphanet J Rare Dis; 2013 Sep 26; 8():151. PubMed ID: 24070122
    [Abstract] [Full Text] [Related]

  • 14. New insights on glucosylated lipids: metabolism and functions.
    Ishibashi Y, Kohyama-Koganeya A, Hirabayashi Y.
    Biochim Biophys Acta; 2013 Sep 26; 1831(9):1475-85. PubMed ID: 23770033
    [Abstract] [Full Text] [Related]

  • 15. Identification of the non-lysosomal glucosylceramidase as beta-glucosidase 2.
    Boot RG, Verhoek M, Donker-Koopman W, Strijland A, van Marle J, Overkleeft HS, Wennekes T, Aerts JM.
    J Biol Chem; 2007 Jan 12; 282(2):1305-12. PubMed ID: 17105727
    [Abstract] [Full Text] [Related]

  • 16. Glucosylceramide and Glucosylsphingosine Quantitation by Liquid Chromatography-Tandem Mass Spectrometry to Enable In Vivo Preclinical Studies of Neuronopathic Gaucher Disease.
    Hamler R, Brignol N, Clark SW, Morrison S, Dungan LB, Chang HH, Khanna R, Frascella M, Valenzano KJ, Benjamin ER, Boyd RE.
    Anal Chem; 2017 Aug 15; 89(16):8288-8295. PubMed ID: 28686011
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ubiquitous transgene expression of the glucosylceramide-synthesizing enzyme accelerates glucosylceramide accumulation and storage cells in a Gaucher disease mouse model.
    Barnes S, Xu YH, Zhang W, Liou B, Setchell KD, Bao L, Grabowski GA, Sun Y.
    PLoS One; 2014 Aug 15; 9(12):e116023. PubMed ID: 25551612
    [Abstract] [Full Text] [Related]

  • 19. Lipids regulate the hydrolysis of membrane bound glucosylceramide by lysosomal β-glucocerebrosidase.
    Abdul-Hammed M, Breiden B, Schwarzmann G, Sandhoff K.
    J Lipid Res; 2017 Mar 15; 58(3):563-577. PubMed ID: 28126847
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic delivery of recombinant glucocerebrosidase enzyme-containing extracellular vesicles to human cells from Gaucher disease patients.
    Janpipatkul K, Sutjarit N, Tangprasittipap A, Chaiamarit T, Innachai P, Suksen K, Chokpanuwat T, Tim-Aroon T, Anurathapan U, Jearawiriyapaisarn N, Tubsuwan A, Bowornpinyo S, Asavapanumas N, Chairoungdua A, Bhukhai K, Hongeng S.
    Orphanet J Rare Dis; 2024 Oct 02; 19(1):363. PubMed ID: 39358794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.